Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)

NCT01154985 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

243

Enrollment

INDUSTRY

Sponsor class

Conditions

Steatohepatitis

Interventions

DRUG: Placebo capsule
DRUG: EPA-E 300 mg capsule
DRUG: EPA-E 300 mg capsule

Sponsor

Mochida Pharmaceutical Company, Ltd.